These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 25736380)
1. OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer Therapies. Booth L; Roberts JL; Tavallai M; Nourbakhsh A; Chuckalovcak J; Carter J; Poklepovic A; Dent P J Cell Physiol; 2015 Aug; 230(8):1982-98. PubMed ID: 25736380 [TBL] [Abstract][Full Text] [Related]
2. GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease. Booth L; Roberts JL; Cash DR; Tavallai S; Jean S; Fidanza A; Cruz-Luna T; Siembiba P; Cycon KA; Cornelissen CN; Dent P J Cell Physiol; 2015 Jul; 230(7):1661-76. PubMed ID: 25546329 [TBL] [Abstract][Full Text] [Related]
3. Nexavar/Stivarga and viagra interact to kill tumor cells. Tavallai M; Hamed HA; Roberts JL; Cruickshanks N; Chuckalovcak J; Poklepovic A; Booth L; Dent P J Cell Physiol; 2015 Sep; 230(9):2281-98. PubMed ID: 25704960 [TBL] [Abstract][Full Text] [Related]
4. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide. Booth L; Roberts JL; Poklepovic A; Gordon S; Dent P Oncotarget; 2017 Jan; 8(1):1449-1468. PubMed ID: 27903966 [TBL] [Abstract][Full Text] [Related]
5. Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs. Booth L; Roberts JL; Cruickshanks N; Grant S; Poklepovic A; Dent P Mol Cancer Ther; 2014 Oct; 13(10):2384-98. PubMed ID: 25103559 [TBL] [Abstract][Full Text] [Related]
6. OSU-03012 interacts with lapatinib to kill brain cancer cells. Booth L; Cruickshanks N; Ridder T; Chen CS; Grant S; Dent P Cancer Biol Ther; 2012 Dec; 13(14):1501-11. PubMed ID: 22990204 [TBL] [Abstract][Full Text] [Related]
7. Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo. Booth L; Albers T; Roberts JL; Tavallai M; Poklepovic A; Lebedyeva IO; Dent P Oncotarget; 2016 Jun; 7(26):40398-40417. PubMed ID: 27259258 [TBL] [Abstract][Full Text] [Related]
8. PDE5 inhibitors enhance celecoxib killing in multiple tumor types. Booth L; Roberts JL; Cruickshanks N; Tavallai S; Webb T; Samuel P; Conley A; Binion B; Young HF; Poklepovic A; Spiegel S; Dent P J Cell Physiol; 2015 May; 230(5):1115-27. PubMed ID: 25303541 [TBL] [Abstract][Full Text] [Related]
9. OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: a role for Nck1 but not Nck2. West NW; Garcia-Vargas A; Chalfant CE; Park MA BMC Cancer; 2013 May; 13():256. PubMed ID: 23706161 [TBL] [Abstract][Full Text] [Related]
10. OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing. Booth L; Cazanave SC; Hamed HA; Yacoub A; Ogretmen B; Chen CS; Grant S; Dent P Cancer Biol Ther; 2012 Feb; 13(4):224-36. PubMed ID: 22354011 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance. Webb T; Carter J; Roberts JL; Poklepovic A; McGuire WP; Booth L; Dent P Cancer Biol Ther; 2015; 16(11):1660-70. PubMed ID: 26417912 [TBL] [Abstract][Full Text] [Related]
12. OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells. Park MA; Yacoub A; Rahmani M; Zhang G; Hart L; Hagan MP; Calderwood SK; Sherman MY; Koumenis C; Spiegel S; Chen CS; Graf M; Curiel DT; Fisher PB; Grant S; Dent P Mol Pharmacol; 2008 Apr; 73(4):1168-84. PubMed ID: 18182481 [TBL] [Abstract][Full Text] [Related]
13. Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function. Booth L; Shuch B; Albers T; Roberts JL; Tavallai M; Proniuk S; Zukiwski A; Wang D; Chen CS; Bottaro D; Ecroyd H; Lebedyeva IO; Dent P Oncotarget; 2016 Mar; 7(11):12975-96. PubMed ID: 26887051 [TBL] [Abstract][Full Text] [Related]
14. PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]. Booth L; Roberts JL; Poklepovic A; Dent P Oncotarget; 2017 Feb; 8(8):13464-13475. PubMed ID: 28088782 [TBL] [Abstract][Full Text] [Related]
15. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486 [TBL] [Abstract][Full Text] [Related]
16. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo. Booth L; Roberts JL; Sander C; Lee J; Kirkwood JM; Poklepovic A; Dent P Oncotarget; 2017 Mar; 8(10):16367-16386. PubMed ID: 28146421 [TBL] [Abstract][Full Text] [Related]
17. OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins. Hamed HA; Yacoub A; Park MA; Eulitt P; Sarkar D; Dimitrie IP; Chen CS; Grant S; Curiel DT; Fisher PB; Dent P Cancer Biol Ther; 2010 Apr; 9(7):526-36. PubMed ID: 20107314 [TBL] [Abstract][Full Text] [Related]
18. Neratinib augments the lethality of [regorafenib + sildenafil]. Booth L; Roberts JL; Rais R; Cutler RE; Diala I; Lalani AS; Hancock JF; Poklepovic A; Dent P J Cell Physiol; 2019 Apr; 234(4):4874-4887. PubMed ID: 30203445 [TBL] [Abstract][Full Text] [Related]
19. PERK-dependent regulation of HSP70 expression and the regulation of autophagy. Park MA; Curiel DT; Koumenis C; Graf M; Chen CS; Fisher PB; Grant S; Dent P Autophagy; 2008 Apr; 4(3):364-7. PubMed ID: 18216498 [TBL] [Abstract][Full Text] [Related]
20. [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells. Booth L; Roberts JL; Poklepovic A; Dent P Cancer Biol Ther; 2017 Sep; 18(9):705-714. PubMed ID: 28812434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]